These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3004712

  • 1. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target.
    Glisson B, Gupta R, Hodges P, Ross W.
    Cancer Res; 1986 Apr; 46(4 Pt 2):1939-42. PubMed ID: 3004712
    [Abstract] [Full Text] [Related]

  • 2. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.
    Glisson B, Gupta R, Smallwood-Kentro S, Ross W.
    Cancer Res; 1986 Apr; 46(4 Pt 2):1934-8. PubMed ID: 3004711
    [Abstract] [Full Text] [Related]

  • 3. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines.
    Robson CN, Hoban PR, Harris AL, Hickson ID.
    Cancer Res; 1987 Mar 15; 47(6):1560-5. PubMed ID: 2434220
    [Abstract] [Full Text] [Related]

  • 4. Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomerase.
    Glisson BS, Sullivan DM, Gupta R, Ross WE.
    NCI Monogr; 1987 Mar 15; (4):89-93. PubMed ID: 2819738
    [Abstract] [Full Text] [Related]

  • 5. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Schwartz RE, Zwelling LA, Kerrigan D, Mattern MR, Charcosset JY, Jacquemin-Sablon A, Kohn KW.
    Cancer Res; 1986 Feb 15; 46(2):611-6. PubMed ID: 3000581
    [Abstract] [Full Text] [Related]

  • 6. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A.
    Cancer Res; 1986 Jun 15; 46(6):3075-81. PubMed ID: 3009009
    [Abstract] [Full Text] [Related]

  • 7. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides.
    Davies SM, Davies SL, Harris AL, Hickson ID.
    Cancer Res; 1989 Aug 15; 49(16):4526-30. PubMed ID: 2545343
    [Abstract] [Full Text] [Related]

  • 8. Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines.
    Spiridonidis CA, Chatterjee S, Petzold SJ, Berger NA.
    Cancer Res; 1989 Feb 01; 49(3):644-50. PubMed ID: 2535964
    [Abstract] [Full Text] [Related]

  • 9. Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line.
    Webb CD, Latham MD, Lock RB, Sullivan DM.
    Cancer Res; 1991 Dec 15; 51(24):6543-9. PubMed ID: 1660341
    [Abstract] [Full Text] [Related]

  • 10. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
    Sullivan DM, Eskildsen LA, Groom KR, Webb CD, Latham MD, Martin AW, Wellhausen SR, Kroeger PE, Rowe TC.
    Mol Pharmacol; 1993 Feb 15; 43(2):207-16. PubMed ID: 8094226
    [Abstract] [Full Text] [Related]

  • 11. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.
    Gupta RS, Gupta R, Eng B, Lock RB, Ross WE, Hertzberg RP, Caranfa MJ, Johnson RK.
    Cancer Res; 1988 Nov 15; 48(22):6404-10. PubMed ID: 2846151
    [Abstract] [Full Text] [Related]

  • 12. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
    Jensen CG, Wilson WR, Bleumink AR.
    Cancer Res; 1985 Feb 15; 45(2):717-25. PubMed ID: 3838148
    [Abstract] [Full Text] [Related]

  • 13. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB.
    Cancer Res; 1998 Apr 01; 58(7):1460-8. PubMed ID: 9537249
    [Abstract] [Full Text] [Related]

  • 14. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1986 Aug 01; 46(8):3809-16. PubMed ID: 3015377
    [Abstract] [Full Text] [Related]

  • 15. Proliferation dependence of topoisomerase II mediated drug action.
    Sullivan DM, Glisson BS, Hodges PK, Smallwood-Kentro S, Ross WE.
    Biochemistry; 1986 Apr 22; 25(8):2248-56. PubMed ID: 3011082
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 17. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
    Rothenborg-Jensen L, Hansen HF, Wessel I, Nitiss JL, Schmidt G, Jensen PB, Sehested M, Jensen LH.
    Anticancer Drug Des; 2001 Dec 01; 16(6):305-15. PubMed ID: 12375883
    [Abstract] [Full Text] [Related]

  • 18. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
    Sullivan DM, Latham MD, Ross WE.
    Cancer Res; 1987 Aug 01; 47(15):3973-9. PubMed ID: 3038304
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells.
    Wilson WR, Harris NM, Ferguson LR.
    Cancer Res; 1984 Oct 01; 44(10):4420-31. PubMed ID: 6547875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.